|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Actelion Ltd., of Allschwil, Switzerland, said it started marketing Tracleer tablets in Germany. By mid-June, patients in the UK also will gain access to Tracleer, an orally available dual endothelin receptor antagonist approved in late May by the European Commission for pulmonary arterial hypertension.
Advanced Viral Research Corp., of Yonkers, N.Y., said its antiviral immunomodulator, Product R, was approved by the Israeli Ministry of Health for Phase I/II trials in patients who have failed highly active antiretroviral therapy and require salvage therapy. The company anticipates the trials will help facilitate the investigational new drug application process ...